雷军投的机器人，要 IPO 了

Core Viewpoint - Beijing Shurui Robot Co., Ltd. is preparing for an IPO, having completed the counseling registration with the Beijing Securities Regulatory Bureau, with CITIC Securities as the counseling institution [2][3] Company Overview - Shurui Robot, founded by Professor Xu Kai from Shanghai Jiao Tong University, focuses on the research, production, and commercialization of single-port minimally invasive surgical robot systems [2][5] - The company aims to break the monopoly of imported brands in the laparoscopic surgical robot market, which has been dominated by high-priced foreign products [5][6] Technological Advancements - Shurui Robot has developed a revolutionary design called "deformable dual-continuum mechanism," which enhances the performance of its surgical robots, making them competitive with top international products [6] - The company’s single-port laparoscopic surgical robot, equipped with high-performance deformable surgical arms, received approval from the National Medical Products Administration (NMPA) in June 2023, marking it as the first in China to cover both urology and gynecology laparoscopic procedures [6][8] Market Position and Intellectual Property - As of April 2025, Shurui Robot has filed over 805 patents globally, establishing a comprehensive intellectual property protection system, positioning itself as a leading company in the domestic single-port minimally invasive laparoscopic surgical robot market [8][9] Funding and Investment - Between 2019 and 2023, Shurui Robot completed six rounds of financing, attracting notable venture capital firms such as Tianfeng Capital and Medtronic, with significant investments from Lei Jun's Shunwei Capital [9] - The founder, Xu Kai, holds a direct stake of 22.74% and controls a total of 54.58% of the voting rights through various partnerships [9]